The Silencing of CCND2 by Promoter Aberrant Methylation in Renal Cell Cancer and Analysis of the Correlation between CCND2 Methylation Status and Clinical Features.
Cyclin D2 (CCND2) is a member of the D-type cyclins, which plays a pivotal role in cell cycle regulation, differentiation and malignant transformation. However, its expression status and relative regulation mechanism remains unclear in renal cell cancer (RCC). In our study, the mRNA expression level...
Main Authors: | Lu Wang, Yun Cui, Lian Zhang, Jindong Sheng, Yang Yang, Guanyu Kuang, Yu Fan, Qian Zhang, Jie Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5008725?pdf=render |
Similar Items
-
Aberrant methylation-mediated downregulation of lncRNA CCND2 AS1 promotes cell proliferation in cervical cancer
by: Chengcheng Zhao, et al.
Published: (2020-06-01) -
LncRNA HOTAIR Regulates CCND1 and CCND2 Expression by Sponging miR-206 in Ovarian Cancer
by: Lei Chang, et al.
Published: (2018-09-01) -
Prognostic impact of glioblastoma stem cell markers OLIG2 and CCND2
by: Christelle Bouchart, et al.
Published: (2020-02-01) -
Cell Cycle Regulation by Alternative Polyadenylation of CCND1
by: Qiong Wang, et al.
Published: (2018-05-01) -
CCND1 silencing suppresses liver cancer stem cell differentiation and overcomes 5-Fluorouracil resistance in hepatocellular carcinoma
by: Hao Ding, et al.
Published: (2020-07-01)